
Sign up to save your podcasts
Or


2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
By Biotechnology Innovation Organization4.9
8383 ratings
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.

31,967 Listeners

3,392 Listeners

488 Listeners

26,346 Listeners

755 Listeners

332 Listeners

498 Listeners

3,990 Listeners

396 Listeners

1,420 Listeners

322 Listeners

1,043 Listeners

263 Listeners

229 Listeners

3,523 Listeners